Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Liver Failure × Raltegravir Potassium × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Liver Failure 1 Leukemia-Lymphoma, Adult T-Cell 1 Hepatitis C 1 Hepatitis B 1 Hepatic Insufficiency 1 Head and Neck Neoplasms 1 HIV Infections 1 Carcinoma, Hepatocellular 1

Interventions

urinastatin 1 sacituzumab govitecan 1 maltodextrin 1 halofantrine 1 Raltegravir Potassium 1 N-monoacetylcystine 1 Glycyrrhizic Acid 1 Everolimus 1 Amino Acids 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01022476 2013-07-18

LIVERAL

ANRS, Emerging Infectious Diseases

Phase 1/2 Completed

Gastrointestinal

Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, HIV Infections, Liver Failure, Hepatic Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡